EFPIA MAPPs - newsletter  

masthead

E-NEWSLETTER
August 4th 2015
littlesq
Interview
littlesq  
Amy Miller 150x150 US Personalized Medicine Coalition: Exploring Pathways Towards Patient-Centred Care 

Adaptive pathways are among the possibilities being examined for incentivising medicine and future innovation in the United States, says Amy M. Miller, Ph.D., Executive Vice President of the Washington DC-based Personalized Medicine Coalition. But some key hurdles remain, not only from a scientific view, but also from a policy perspective. Dialogue and an exchange of ideas between the US and the EU can help spur progress.

READ THE FULL INTERVIEW...

 
Blog
littlesq  
imi2littlesq MAPPs and New Benefit Risk Models: IMI2 Leads with Patient Engagement

EFPIA's Director Science Policy Magda Chlebus blogs about the 5th call for proposals from the second Innovative Medicines Initiative. Topic 1 addresses one of the key enablers of adaptive pathways - developing methods to incorporate the input of patients into the assssments of benefits and risks of medicines at all stages of the drug development life cycle.

READ THE FULL BLOG...

 

News
littlesq  
EMA LOGOlittlesq EMA Announces 2 Public Consultations on Revised Guidelines on Accelerated Assessment and Conditional Marketing Authorisation

The European Medicines Agency (EMA) has revised its guidelines on the implementation of accelerated assessment and conditional marketing authorisation, two key tools in the European legislation to accelerate patients' access to medicines that address unmet medical needs.

READ THE FULL ANNOUNCEMENT...

 

 
Upcoming Event
littlesq  
BSBH-small 3

 
Better Science, Better Health: New Healthcare Models
Washington D.C. - October 27th - 28th 

There are multiple global initiatives currently investigating ways to improve and accelerate the way we bring needed new medicines to patients. How do we collaborate internationally to create better outcomes in the emerging world of precision medicine?

Featuring:  
  • Mark Berger, Vice President, Real World Data and Analytics, Pfizer
  • Jeff Brown, Associate Professor Population Medicine, Harvard Medical School
  • Rob Califf, Deputy Commissioner for Medical Products and Tobacco, US FDA
  • Magda Chlebus, Director Science Policy, EFPIA
  • Ruxandra Draghia-Akli, Director Health, DG Research and Innovation, European Commission
  • Hans-Georg Eichler, Senior Medical Officer, European Medicine’s Agency
  • Laura Esserman, Professor of Surgery and Radiology, Director UCSF Carol Franc Buck Breast Care Center
  • Pat Furlong, Founding President and CEO, Parent Project Muscular Dystrophy
  • Sarah Garner, Associate Director Science Policy and Research, NICE
  • Joseph P. Hammang, Partner, Vital Transformation
  • Gigi Hirsch, Executive Director, MIT NewDig
  • Alastair Kent, Director, Genetic Alliance UK
  • Barbara Lopez Kunz, Global CEO, DIA
  • Irene Norstedt, Acting Executive Director, Innovative Medicine’s Initiative
  • Anders Olauson, President, European Patients' Forum
  • Kenneth A. Oye, Associate Professor of Political Science and Engineering Systems, MIT
  • Mark Pearson, Head of the Health Division, OECD
  • Arti K. Rai, Elvin R. Latty Professor of Law and Co-Director, Duke Law Center for Innovation Policy, Duke University
  • Bettina Ryll, Founder, Melanoma Patient Network 
  • Peter L. Saltonstall, CEO, National Organization of Rare Disorders (NORD)
  • Vicki Seyfert-Margolis, CEO, My Own Med
  • Mark Trusheim, Researcher, MIT Sloan School of Management
  • Bart Vannieuwenhuyse, Senior Director Health Information Sciences, Janssen Pharmaceuticals

REQUEST YOUR INVITATION...

 
 
EFPIA Brussels Office
littlesq  
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: anna.szczepanska@efpia.eu or science-policy@efpia.eu 
littlesq

footer

littlesq

 




Click to view this email in a browser

If you no longer wish to receive these emails, please reply to this message with "Unsubscribe" in the subject line or simply click on the following link: Unsubscribe

Vital Transformation
107 Leopold III Laan
Wezembeek-Oppem, 1970
Belgium

Read the VerticalResponse marketing policy.

Try Email Marketing with VerticalResponse!